Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × daratumumab × 30 days × Clear all

Phase

Status

Recruiting 21 Active not recruiting 20 Not yet recruiting 4 Withdrawn 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Multiple Myeloma 1

Interventions

Cyclophosphamide 21 pembrolizumab 18 Cisplatin 17 Gemcitabine 15 Nivolumab 14 Paclitaxel 11 Dexamethasone 11 fludarabine 10 Blood Specimen Collection 10 palbociclib 8 Radiotherapy 8 Lenalidomide 8 Exercise 8 Carboplatin 8 Bortezomib 8 Rituximab 7 Docetaxel 7 Biopsy 6 durvalumab 5 atezolizumab 5 Vincristine 5 Trastuzumab 5 Tamoxifen 5 Specimen Handling 5 Prednisone 5 Oxaliplatin 5 Letrozole 5 Irinotecan 5 Ipilimumab 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02626481 2026-04-07

IFM2014-04

University Hospital, Lille

Phase 2 Completed

Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡